Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Martin

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|July 3, 2024
Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development toolJuan Francisco Morales, Marian Klose, Yannick Hoffert, et al.
Critical Care (London, England)|April 6, 2019
Sequential organ failure assessment score is an excellent operationalization of disease severity of adult patients with hospitalized community acquired pneumonia - results from the prospective observational PROGRESS studyPeter Ahnert, Petra Creutz, Katrin Horn, et al.
Drug Testing and Analysis|March 22, 2021
Assessment of biological matrices for the detection of in utero cannabis exposureMarta Concheiro, Frank Martin Gutierrez, Alejandro Ocampo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 4, 2024
The pectus care guidelines: best practice consensus guidelines from the joint specialist societies SCTS/MF/CWIG/BOA/BAPS for the treatment of patients with pectus abnormalitiesJoel Dunning, Clare Burdett, Anne Child, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 15, 2023
Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studiesJuan Francisco Morales, Rhoda Muse, Jagdeep T Podichetty, et al.
Diabetologia|October 5, 2018
Detection and quantification of beta cells by PET imaging: why clinical implementation has never been closerMartin Gotthardt, Decio L Eizirik, Henk-Jan Aanstoot, et al.
Microbiology Spectrum|March 6, 2024
Phylogenomics reveals extensive misidentification of fungal strains from the genus <i>Aspergillus</i>Jacob L Steenwyk, Charu Balamurugan, Huzefa A Raja, et al.
Plos One|September 17, 2008
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosisMarco Cassano, Stefano Biressi, Amanda Finan, et al.
Plos One|July 25, 2019
Correction: Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from ApoptosisMarco Cassano, Stefano Biressi, Amanda Finan, et al.
Human Mutation|December 24, 2015
Sporadic and Familial Congenital Cataracts: Mutational Spectrum and New Diagnoses Using Next-Generation SequencingAlan S Ma, John R Grigg, Gladys Ho, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
CPT: Pharmacometrics & Systems Pharmacology|July 3, 2024
Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development toolJuan Francisco Morales, Marian Klose, Yannick Hoffert, et al.
Critical Care (London, England)|April 6, 2019
Sequential organ failure assessment score is an excellent operationalization of disease severity of adult patients with hospitalized community acquired pneumonia - results from the prospective observational PROGRESS studyPeter Ahnert, Petra Creutz, Katrin Horn, et al.
Drug Testing and Analysis|March 22, 2021
Assessment of biological matrices for the detection of in utero cannabis exposureMarta Concheiro, Frank Martin Gutierrez, Alejandro Ocampo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 4, 2024
The pectus care guidelines: best practice consensus guidelines from the joint specialist societies SCTS/MF/CWIG/BOA/BAPS for the treatment of patients with pectus abnormalitiesJoel Dunning, Clare Burdett, Anne Child, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 15, 2023
Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studiesJuan Francisco Morales, Rhoda Muse, Jagdeep T Podichetty, et al.
Diabetologia|October 5, 2018
Detection and quantification of beta cells by PET imaging: why clinical implementation has never been closerMartin Gotthardt, Decio L Eizirik, Henk-Jan Aanstoot, et al.
Microbiology Spectrum|March 6, 2024
Phylogenomics reveals extensive misidentification of fungal strains from the genus <i>Aspergillus</i>Jacob L Steenwyk, Charu Balamurugan, Huzefa A Raja, et al.
Plos One|September 17, 2008
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosisMarco Cassano, Stefano Biressi, Amanda Finan, et al.
Plos One|July 25, 2019
Correction: Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from ApoptosisMarco Cassano, Stefano Biressi, Amanda Finan, et al.
Human Mutation|December 24, 2015
Sporadic and Familial Congenital Cataracts: Mutational Spectrum and New Diagnoses Using Next-Generation SequencingAlan S Ma, John R Grigg, Gladys Ho, et al.
Pageof 17